NFL BIOSCIENCES (EPA:ALNFL)

REGULATED PRESS RELEASE

published on 03/29/2024 at 17:45, 2 years 3 months ago

NFL BIOSCIENCES: 2023 FULL-YEAR BUSINESS AND EARNINGS UPDATE
BRIEF

published on 03/11/2024 at 09:00, 2 years 4 months ago

NFL BIOSCIENCES: INITIATION OF ANALYST COVERAGE BY PORTZAMPARC - BNP PARIBAS GROUP

NFL Biosciences PORTZAMPARC BNP Paribas Biopharmaceutical Industry Analyst Coverage
BRIEF

published on 03/11/2024 at 09:00, 2 years 4 months ago

NFL BIOSCIENCES : INITIATION DE COUVERTURE ANALYSTE PAR PORTZAMPARC – GROUPE BNP PARIBAS

Marché Financier NFL Biosciences PORTZAMPARC BNP Paribas Couverture Analyste
REGULATED PRESS RELEASE

published on 03/11/2024 at 08:55, 2 years 4 months ago

NFL BIOSCIENCES: INITIATION OF ANALYST COVERAGE BY PORTZAMPARC - BNP PARIBAS GROUP
REGULATED PRESS RELEASE

published on 03/11/2024 at 08:55, 2 years 4 months ago

NFL BIOSCIENCES : INITIATION DE COUVERTURE ANALYSTE PAR PORTZAMPARC – GROUPE BNP PARIBAS
ARTICLE

published on 02/13/2024 at 18:45, 2 years 5 months ago

NFL BIOSCIENCES ANNONCE SA PARTICIPATION AU CONGRÈS DE LA SRNT
Présentation des résultats prometteurs de l'étude PRECESTO dans la lutte contre le tabagisme

NFL Biosciences Innovation NFL-101 Tabagisme SRNT
REGULATED PRESS RELEASE

published on 02/13/2024 at 17:45, 2 years 5 months ago

NFL BIOSCIENCES WILL PRESENT THE RESULTS OF THE PRECESTO CLINICAL STUDY AT THE SRNT CONFERENCE, THE WORLD'S LEADING SCIENTIFIC SOCIETY IN THE FIELD OF NICOTINE AND TOBACCO RESEARCH
NFL Biosciences to present promising results of the PRECESTO clinical study at the SRNT Conference, focusing on smoking cessation with botanical drug NFL-101. Phase 2b trial ongoing for CESTO 2

NFL Biosciences Smoking Cessation NFL-101 PRECESTO Study CESTO 2
REGULATED PRESS RELEASE

published on 02/13/2024 at 17:45, 2 years 5 months ago

NFL BIOSCIENCES PRÉSENTERA LES RÉSULTATS DE L’ÉTUDE PRECESTO LORS DU CONGRÈS DE LA SRNT, LA SOCIÉTÉ SCIENTIFIQUE DE RÉFÉRENCE AU NIVEAU MONDIAL DANS LA LUTTE CONTRE LE TABAGISME
NFL Biosciences présentera les résultats de l'étude PRECESTO lors du congrès de la SRNT à Édimbourg le 20-23 mars 2024, montrant l'efficacité de NFL-101 dans la réduction de la satisfaction de fumer

NFL Biosciences NFL-101 Étude PRECESTO Tabagisme SRNT
REGULATED PRESS RELEASE

published on 01/30/2024 at 08:00, 2 years 5 months ago

NFL BIOSCIENCES: SUCCESS OF THE STUDY WITH THE CEA
NFL BIOSCIENCES announces the successful study with the CEA demonstrating a new mechanism of action for smoking cessation using NFL-101, a botanical drug. Results open new possibilities for addiction treatment

NFL Biosciences Addiction Treatment CEA Study Smoking Cessation NFL-101
REGULATED PRESS RELEASE

published on 01/30/2024 at 08:00, 2 years 5 months ago

NFL BIOSCIENCES : SUCCÈS DE L’ÉTUDE AVEC LE CEA
NFL BIOSCIENCES annonce la mise en ubrique, étude d'imagerie moléculaire menée par le CEA, du mécanisme d'action innovant du candidat médicament NFL-101 pour le sevrage tabagique

NFL Biosciences Étude D'imagerie Moléculaire Sevrage Tabagique CEA Mécanisme D'action

Published on 07/21/2026 at 23:00, 2 hours 58 minutes ago

Viemed Healthcare Announces Second Quarter 2026 Earnings Conference Call Details
Published on 07/21/2026 at 22:30, 3 hours 28 minutes ago

Fermi Announces First Siemens Turbines Arrive at Port of Houston
Published on 07/21/2026 at 22:30, 3 hours 28 minutes ago

Matador Technologies Announces Management Transition
Published on 07/21/2026 at 22:15, 3 hours 43 minutes ago

Vanta Announces Updated Time for Participation in the "Health, Wellness & Longevity" Virtual Conference Presented by Maxim Group LLC on Wednesday, July 22, 2026, at 12:00 p.m. ET
Published on 07/21/2026 at 22:00, 3 hours 58 minutes ago

Redwood AI Announces Closing of $3.5 Million Private Placement

View all ACCESSWIRE

Published on 07/22/2026 at 01:05, 52 minutes ago

Quantinuum and SoftBank Corp. Publish Joint White Paper on Scaling Practical Quantum Computing Use Cases Toward the Fault-Tolerant Era
Published on 07/21/2026 at 22:30, 3 hours 27 minutes ago

Strong second quarter: GEA raises full-year guidance for 2026
Published on 07/21/2026 at 22:16, 3 hours 41 minutes ago

EQS-Adhoc: GEA Group Aktiengesellschaft: Preliminary numbers for Q2 2026 exceed market expectation - increase of guidance for fiscal year 2026
Published on 07/21/2026 at 18:50, 7 hours 7 minutes ago

Soapeya, a DN Group AG Portfolio Company, Earns Top "Excellent" Rating from Dermatest and Proves Successful in Field Use in Ghana
Published on 07/21/2026 at 18:15, 7 hours 42 minutes ago

EuroTeleSites Reports Strong Q2/2026 Results with Growth Across Key Financial and Operating Metrics

View all EQS

Published on 07/21/2026 at 19:02, 6 hours 55 minutes ago

KLARSEN : Résultats annuels 2025
Published on 07/21/2026 at 18:41, 7 hours 16 minutes ago

ICADE - Rapport Financier Semestriel 2026
Published on 07/21/2026 at 18:41, 7 hours 16 minutes ago

ICADE - 2026 HY Financial Report
Published on 07/21/2026 at 18:13, 7 hours 44 minutes ago

ICADE – PR – 2026 HALF YEAR RESULTS
Published on 07/21/2026 at 18:13, 7 hours 44 minutes ago

ICADE – CP – RESULTATS SEMESTRIELS 2026

View all LES ECHOS COMFI WIRE

News